Categories: DesignDevelopmentDrugPlatform
Vasa Therapeutics is developing multiple novel therapies for vascular disease and heart failure
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.01.2024 | Seed | $6M | - |
Mentions in press and media 7
| Date | Title | Description |
| 04.01.2024 | Vasa Therapeutics Raises $6 Million In Seed Funding To Develop Therapies For Cardiovascular Aging Diseases | Vasa Therapeutics – a preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging – recently announced the closing of $6 million in series seed funding led by Orphinic Scientific SA. The funding round als... |
| 03.01.2024 | Vasa Therapeutics acquires $6M in Seed funding to advance novel therapies for cardiovascular diseases | - |
| 03.01.2024 | Vasa Therapeutics Closes Seed Funding | Vasa Therapeutics, an Encinitas, CA-based preclinical stage biopharmaceutical company developing novel therapies for cardiovascular aging, closed a Seed funding of $6M supplemented by $2.3M non-dilutive grant funding.
The round was led by O... |
| 03.01.2024 | Vasa Therapeutics raises $6M to develop drugs targeting heart failure | The company will be starting phase one trials of its first drug in Q2 2024
Cardiovascular disease is the leading cause of mortality and morbidity globally, accounting for more than 17 million deaths worldwide each year, a figure expected to... |
| 03.01.2024 |
Vasa Therapeutics Snags Seed Funding
| Encinitas-based Vasa Therapeutics, a preclinical stage biopharmaceutical company developing therapies for cardiovascular aging, says it has raised $6M in a seed funding round. The funding was led by Orphinic Scientific SA, and also NuFund V... |
| 03.01.2024 | Vasa Therapeutics Closes $6M Seed Financing |
ENCINITAS, CA, Vasa Therapeutics announced the closing of a $6M series seed funding led by Orphinic Scientific SA.
>> Click here for more funding data on Vasa Therapeutics
>> To export Vasa Therapeutics funding data to PDF a... |
| - | Vasa Therapeutics | “Vasa-Therapeutics-2022” |
Reviews 0
